An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With Ankylosing Spondylitis

Investigation of 9 Consecutive Remicade Infusions in Ankylosing Spondylitis in Austria (Study P04044)(COMPLETED)

NCT00725543 ·Status: COMPLETED

Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes

NCT02469753 ·Status: COMPLETED ·Phase: PHASE3

A Study of CC-99677 in Participants With Active Ankylosing Spondylitis

NCT04947579 ·Status: TERMINATED ·Phase: PHASE2

Growth Factor Concentration to Predict an Ankylosing Spondylitis Patient's Response to Infliximab (Study P04041)(COMPLETED)

NCT00779935 ·Status: COMPLETED ·Phase: PHASE4

Novel MRI ANd Biomarkers in GOlimumab-treated Patients With Axial Spondyloarthritis

NCT02011386 ·Status: COMPLETED

16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis

NCT02159053 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Long Term Safety and Efficacy of Bimekizumab in Subjects With Ankylosing Spondylitis

NCT03355573 ·Status: COMPLETED ·Phase: PHASE2

Mechanistic Studies of B- and T-Cell Function in RA Patients Treated With TNF Antagonists, Tocilizumab, or Abatacept

NCT02353780 ·Status: TERMINATED ·Phase: PHASE4

An Evaluation of the Optimal Dose of Tofacitinib Needed to Achieve Low Disease Activity (LDA) or Clinical Remission in Patients With Active Rheumatoid Arthritis (RA) as Measured From a Clinical and Structural Perspective

NCT02566967 ·Status: COMPLETED ·Phase: PHASE3

Long Term Safety Study of Tanezumab in Chronic Low Back Pain

NCT00924664 ·Status: TERMINATED ·Phase: PHASE2

REMission INDuction in Very Early Rheumatoid Arthritis

NCT02935387 ·Status: TERMINATED ·Phase: PHASE4

An Observational Study of Infliximab in Participants Suffering From Ankylosing Spondylitis With Hip Involvement

NCT02293681 ·Status: TERMINATED

An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants

NCT00760669 ·Status: COMPLETED

Safety Study of Remsima® (Infliximab) in Rheumatoid Arthritis Patients in Jordan

NCT03348046 ·Status: COMPLETED

A Study of the Safety and Efficacy of Golimumab in Subjects With Active Ankylosing Spondylitis

NCT00265083 ·Status: COMPLETED ·Phase: PHASE3

Sub-cutaneous Infliximab in Inflammatory Rheumatic Disease

NCT05424926 ·Status: COMPLETED

A Study of Golimumab in Participants With Active Ankylosing Spondylitis

NCT02186873 ·Status: COMPLETED ·Phase: PHASE3

Bone MicroArchitecture Abatacept (BMA2)

NCT02675218 ·Status: TERMINATED

Remicade in the Treatment of Patients With Active Ankylosing Spondylitis

NCT01850121 ·Status: COMPLETED

Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo

NCT02505542 ·Status: COMPLETED ·Phase: PHASE3

Measurement of the Structural Efficacy in Active RA Patients Treated With Sarilumab in Combination With MTX and Naive to Biologics

NCT03535402 ·Status: UNKNOWN ·Phase: PHASE3

A Study to Investigate the Use of Golimumab (Simponi®) in Participants With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (P06554)

NCT01313858 ·Status: COMPLETED

Multicenter, Post-marketing, Non-interventional, Observational Study in RA Patients Treated With RoActemra/Actemra (Tocilizumab)

NCT02101307 ·Status: COMPLETED

A Study on Rheumatoid Arthritis Patients Treated With Rituximab

NCT02622503 ·Status: COMPLETED

A Study to Evaluate the Efficacy and Safety of Different Doses of Bimekizumab in Subjects With Active Ankylosing Spondylitis

NCT02963506 ·Status: COMPLETED ·Phase: PHASE2